Authors:
KELLEHER AD
ROGGENSACK M
JARAMILLO AB
SMITH DE
WALKER A
GOW I
MCMURCHIE M
HARRIS J
PATOU G
COOPER DA
Citation: Ad. Kelleher et al., SAFETY AND IMMUNOGENICITY OF A CANDIDATE THERAPEUTIC VACCINE, P24 VIRUS-LIKE PARTICLE, COMBINED WITH ZIDOVUDINE, IN ASYMPTOMATIC SUBJECTS, AIDS, 12(2), 1998, pp. 175-182
Authors:
KLEIN MR
VEENSTRA J
HOLWERDA AM
ROOS MTL
GOW I
PATOU G
COUTINHO RA
DEWOLF F
MIEDEMA F
Citation: Mr. Klein et al., GAG-SPECIFIC IMMUNE-RESPONSES AFTER IMMUNIZATION WITH P17 P24-TY VIRUS-LIKE PARTICLES IN HIV TYPE 1-SEROPOSITIVE INDIVIDUALS/, AIDS research and human retroviruses, 13(5), 1997, pp. 393-399
Authors:
SMITH DE
BOAG F
COLEBUNDERS R
WELLER IVD
TCHAMOUROFF S
WEBER J
GOW I
PATOU G
COOPER DA
Citation: De. Smith et al., THERAPEUTIC VACCINATION (P24-VLP) OF PATIENTS WITH ADVANCED HIV-1 INFECTION DOES NOT ALTER CD4 DECLINE, AIDS, 10, 1996, pp. 65-65
Citation: A. Walker et al., THE ASSOCIATION BETWEEN CD38 EXPRESSION ON T-CELLS AND DELAYED-TYPE HYPERSENSITIVITY (DTH) RESPONSE INCLUDING TUBERCULIN REACTIVITY IN ASYMPTOMATIC HIV-SEROPOSITIVE INDIVIDUALS, AIDS, 10, 1996, pp. 114-114
Authors:
KELLEHER AD
SMITH DE
COOPER DA
WALKER A
GOW I
PATOU G
Citation: Ad. Kelleher et al., EFFECT OF THERAPEUTIC VACCINATION (P24-VLP) AND AZT ON IMMUNOLOGICAL MARKERS IN EARLY HIV DISEASE, AIDS, 10, 1996, pp. 137-137